The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
ADJUNCTIVE metformin at 2.0 g/day significantly improves BMI, insulin requirements, and lipid profiles in adolescents with ...
Metformin is a safe and effective oral medication for people with type 2 diabetes. Here's how it can help regulate ...
The ACHIEVE-5 trial (ClinicalTrials.gov identifier: NCT06109311) was a randomized, double-blind, placebo-controlled study that included 546 T2D patients with inadequate glycemic control on insulin ...
Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.
The Endocrine Society and European Society of Endocrinology issued recommendations for the management of preexisting diabetes ...
Two Ohio bills that may have effects on abortion medication and access were considered in separate Ohio House committees this ...
Insights from ECTRIMS 2025, including anticipated presentations, key takeaways, and how emerging research on DMTs in RRMS may ...
Exploring the anti-diabetic potential of the chaya plant and its benefits for managing blood sugar and improving metabolic ...
Eli Lilly (LLY) stock is in focus as the company's oral weight loss candidate orforglipron succeeds in two Phase 3 trials for ...
Prediabetes is becoming a major health challenge in India, especially among young adults. Early screening and preventive treatments like metformin could reduce future diabetes burden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback